We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adverse Events Show Slight Rise in FDA Surveillance & Epidemiology Annual Report
Adverse Events Show Slight Rise in FDA Surveillance & Epidemiology Annual Report
CDER’s Office of Surveillance and Epidemiology (OSE) 2022 Annual Report showed the total number of adverse event (AE) reports rose slightly from 2.23 million in 2021 to 2.34 million, capturing patient adverse reactions along with medication error reports and product quality complaints.